You are here

Bayer

Merck plans to count coughs and months until gefapixant is back in FDA hands

Fierce Biotech

Fri, 08/5/22 - 10:54 am

Bayer CEO Werner Baumann says company is 'putting major litigation behind us' while highlighting Q2 growth

Endpoints

Thu, 08/4/22 - 06:15 pm

July Brings Layoffs, Job Creation for the Life Sciences

BioSpace

Wed, 08/3/22 - 09:32 pm

Eikon Therapeutics

Heron Therapeutics

Adverum Biotechnologies

X4 Pharmaceuticals

Assembly Biosciences

Bayer-Ionis' anti-thrombotic med doesn't increase bleeding in phase 2, setting stage for a new type of anticoagulant

Fierce Biotech

Thu, 07/28/22 - 05:54 pm

Ionis Pharmaceuticals

clinical trials

In $500M deal, Bayer offloads testosterone deficiency drug Nebido to Grünenthal

Fierce Pharma

Thu, 07/14/22 - 07:58 pm

Follow-Up Data on Bayer’s Larotrectinib Hints at Potentially Curative Impact

BioSpace

Thu, 07/7/22 - 10:29 am

Bayer AG opens Kendall Square research center focused on cancer

Boston Globe, MA

Fri, 07/1/22 - 09:46 am

Move over Medtech, Pharma Is Embracing AI, Too!

Medical Devices and Diagnostics Industry

Wed, 06/29/22 - 05:29 pm

machine learning

artificial intelligence

ADA: Bayer builds its case for potential kidney disease blockbuster Kerendia

Fierce Pharma

Tue, 06/7/22 - 10:13 am

chronic kidney disease

Bayer pulls plug on $670M CAR-T cell therapy pact with Atara in wake of patient death

Fierce Biotech

Fri, 05/20/22 - 10:22 am

Atara Biotherapeutics

clinical trials

Bayer's farming business drives Q1 earnings beat

Yahoo/Reuters

Tue, 05/10/22 - 10:53 am

Aiming to treat Parkinson’s by replacing neurons, Aspen Neuroscience nabs $147M

MedCity News

Mon, 05/9/22 - 11:22 pm

Parkinson's Disease

Bayer's Nubeqa one step closer to blockbuster status thanks to FDA priority review in potential new use

Fierce Pharma

Tue, 05/3/22 - 10:48 pm

prostate cancer

Bayer nabs yet another oncology leader from GSK to bolster cancer efforts

Fierce Biotech

Fri, 04/22/22 - 10:34 am

First-quarter biotech risers work hard for the win

EP Vantage

Thu, 04/21/22 - 10:32 am

Lantheus Medical

ACC: Bayer’s Kerendia cuts cardio and kidney complications in high-risk patients

Fierce Pharma

Mon, 04/4/22 - 11:20 pm

Running behind Bristol Myers and J&J, Bayer inches forward in the next-gen blood thinner race

Endpoints

Mon, 04/4/22 - 10:56 am

clinical trials

Bristol Myers Squibb

Bayer reloads Leaps with €1.3 billion to step up investments in biotech innovation

MedCity News

Mon, 04/4/22 - 10:19 am

artificial intelligence

A Bayer partner slims down, trimming R&D and enacting layoffs, to better focus on the pair's prostate cancer work

Endpoints

Thu, 03/24/22 - 10:53 am

prostate cancer

Bayer-backed Affini-T snags $175M to enter increasingly crowded KRAS-cancer field

Fierce Biotech

Tue, 03/22/22 - 10:09 am

Affini-T Therapeutics

venture capital

Pages